Dasatinib-sprycel (20mg, 50mg, 70mg, 100 mg)

Bristol-Myers Squibb

“Dasatinib” is the Drug / Molecules content in “Sprycel”. It belongs to a class of medications protein tyrosine kinase inhibitor (TKI). Dasatinib blocks and interferes with how cells make a number of protein kinases and is called a multi kinase inhibitor. It will works by blocking the signals to grow.

Indication

Sprycel is used for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia.

Note

Precaution

  • Sprycel is a prescription drug and should be used under proper medical guidance and advice.
  • Neutropenia and myelosuppression were common toxic effects.